| Hypoglycemia in diabetes PE Cryer, SN Davis, H Shamoon Diabetes care 26 (6), 1902-1912, 2003 | 1971 | 2003 |
| Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) PA Cleary, W Dahms, D Goldstein, J Malone, WV Tamborlane J Pediatr 139 (1), 804-12, 2001 | 602 | 2001 |
| Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and … TWT for the Diabetes, ... JAMA: the journal of the American Medical Association 290 (16), 2159, 2003 | 524 | 2003 |
| Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. N Cohen, M Halberstam, P Shlimovich, CJ Chang, H Shamoon, L Rossetti The Journal of clinical investigation 95 (6), 2501-2509, 1995 | 486 | 1995 |
| Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans H Shamoon, R Hendler, RS Sherwin The Journal of Clinical Endocrinology & Metabolism 52 (6), 1235-1241, 1981 | 371 | 1981 |
| Reliability of blood glucose monitoring by patients with diabetes mellitus RS Mazze, H Shamoon, R Pasmantier, D Lucido, J Murphy, K Hartmann, ... The American journal of medicine 77 (2), 211-217, 1984 | 362 | 1984 |
| The effect of intensive treatment of diabetic retinopathy in insulin-dependent diabetes mellitus. The diabetes control and complications trial Diabetes Control and Complications Trial Research Group Arch ophthalmol 113, 36-51, 1995 | 359 | 1995 |
| The Diabetes Prevention Program: baseline characteristics of the randomized cohort Diabetes Prevention Program Research Group Diabetes care 23 (11), 1619, 2000 | 344 | 2000 |
| Psychological and social correlates of glycemic control RS Mazze, D Lucido, H Shamoon Diabetes care 7 (4), 360-366, 1984 | 342 | 1984 |
| Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects M Halberstam, N Cohen, P Shlimovich, L Rossetti, H Shamoon Diabetes 45 (5), 659-666, 1996 | 306 | 1996 |
| Epidemiology of Diabetes Interventions and Complications (EDIC): design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and … Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group Diabetes care 22 (1), 99, 1999 | 281 | 1999 |
| Hypoglycemia PE Cryer, JN Fisher, H Shamoon Diabetes care 17 (7), 734-755, 1994 | 279 | 1994 |
| Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes VL Grotz, RR Henry, JB McGill, MJ Prince, H Shamoon, JR Trout, ... Journal of the American Dietetic Association 103 (12), 1607-1612, 2003 | 217 | 2003 |
| Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort Z Chen, F Miao, AD Paterson, JM Lachin, L Zhang, DE Schones, X Wu, ... Proceedings of the National Academy of Sciences 113 (21), E3002-E3011, 2016 | 214 | 2016 |
| Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics: a mechanism for diabetic instability H Shamoon, R Hendler, RS Sherwin Diabetes 29 (4), 284-291, 1980 | 201 | 1980 |
| Counterregulatory adaptation to recurrent hypoglycemia in normal humans MR Davis, H Shamoon The Journal of Clinical Endocrinology & Metabolism 73 (5), 995-1001, 1991 | 198 | 1991 |
| Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM: results of two … DC Simonson, IA Kourides, M Feinglos, H Shamoon, CT Fischette, ... Diabetes Care 20 (4), 597-606, 1997 | 192 | 1997 |
| Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. M Mevorach, A Giacca, Y Aharon, M Hawkins, H Shamoon, L Rossetti The Journal of clinical investigation 102 (4), 744-753, 1998 | 179 | 1998 |
| Effects of the Type 2 Diabetes-Associated PPARG P12A Polymorphism on Progression to Diabetes and Response to Troglitazone JC Florez, KA Jablonski, MW Sun, N Bayley, SE Kahn, H Shamoon, ... The Journal of Clinical Endocrinology & Metabolism 92 (4), 1502-1509, 2007 | 166 | 2007 |
| Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. I Gabriely, R Wozniak, M Mevorach, J Kaplan, Y Aharon, H Shamoon Diabetes Care 22 (12), 2026-2032, 1999 | 145 | 1999 |
Charles BaschColumbia UniversityVerified email at tc.columbia.edu
